Literature DB >> 30012300

Treatment of Recurrent Dupuytren Disease.

Frederick Thomas D Kaplan1, Nicholas E Crosby2.   

Abstract

Treatment of recurrent Dupuytren disease is challenging. Multiple options exist, each having relative benefits and weaknesses. Choice for optimal treatment is made on a case-by-case basis, with shared decision making with the patient. Percutaneous and enzymatic techniques are best reserved for patients with well-defined recurrent disease and offer the benefit of quicker recovery with minimal or no scarring. Surgical treatments have higher risks of neurovascular injury and scarring, but lower recurrence rates. Staged continuous passive elongation followed by dermofasciectomy may lower neurovascular injury and improve outcomes. Salvage procedures may be necessary in patients with poor tissue beds and neurovascular compromise.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aponeurotomy; Collagenase Clostridium histolyticum; Continuous passive elongation; Dermofasciectomy; Dupuytren disease; Outcomes; Recurrence

Mesh:

Substances:

Year:  2018        PMID: 30012300     DOI: 10.1016/j.hcl.2018.03.009

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  2 in total

1.  Versatility of percutaneous needle fasciotomy for Dupuytren's disease across a spectrum of disease severity: A single-surgeon experience of 118 rays.

Authors:  Manal I A Patel; Irshad A Patel
Journal:  JPRAS Open       Date:  2020-11-30

2.  The Effect of Shock Wave Therapy on Improving the Symptoms and Function of Patients with Dupuytren's Contracture.

Authors:  Parisa Taheri; Najmeh Salek; Maryam Mousavi; Razieh Maghroori
Journal:  Adv Biomed Res       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.